PenalizedSVM: a R-package for feature selection SVM classificationBECKER, Natalia; WERFT, Wiebke; TOEDT, Grischa et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 13, pp 1711-1712, issn 1367-4803, 2 p.Article

Soluble iC3b as an Early Marker for Pancreatic Adenocarcinoma Is Superior to CA19.9 and RadiologyMÄRTEN, Angela; BÜCHLER, Markus W; WERFT, Wiebke et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 2, pp 219-224, issn 1524-9557, 6 p.Article

Adult and Pediatric Medulloblastomas Are Genetically Distinct and Require Different Algorithms for Molecular Risk StratificationKORSHUNOV, Andrey; REMKE, Marc; REIFENBERGER, Guido et al.Journal of clinical oncology. 2010, Vol 28, Num 18, pp 3054-3060, issn 0732-183X, 7 p.Article

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancerMARME, Frederik; WERFT, Wiebke; BRETZ, Niko et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 819-831, issn 0167-6806, 13 p.Article

High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-β and PI3K-AKT pathways and deletions at 6q 15-16.1 as a genomic marker for unfavorable early treatment responseREMKE, Marc; PFISTER, Stefan; WITTMANN, Andrea et al.Blood. 2009, Vol 114, Num 5, pp 1053-1062, issn 0006-4971, 10 p.Article